FIQIX | FISMX | FIQIX / FISMX | |
Total Expense Ratio | 0.92 | 1.00 | 92% |
Annual Report Gross Expense Ratio | 0.92 | 1.00 | 92% |
Fund Existence | 7 years | 23 years | - |
Gain YTD | 21.619 | 21.543 | 100% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.07B | 5.07B | 100% |
Annual Yield % from dividends | 2.33 | 2.25 | 103% |
Returns for 1 year | 15.18 | 15.07 | 101% |
Returns for 3 years | 42.51 | 42.02 | 101% |
Returns for 5 years | 58.99 | 56.68 | 104% |
Returns for 10 years | N/A | 68.09 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FRBRX | 141.34 | 1.72 | +1.23% |
Franklin Biotechnology Discovery R6 | |||
PSPFX | 4.56 | 0.02 | +0.44% |
US Global Investors Global Res | |||
SFLNX | 30.08 | -0.06 | -0.20% |
Schwab Fundamental US Large Company Idx | |||
STCZX | 17.64 | -0.04 | -0.23% |
Virtus Silvant Large-Cap Growth Stk R6 | |||
PSLIX | 30.41 | -0.13 | -0.43% |
Principal SmallCap Inst |